Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Equity Ratio (2024 - 2025)

Historic Equity Ratio for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to 0.37.

  • Kura Oncology's Equity Ratio fell 5779.69% to 0.37 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.37, marking a year-over-year decrease of 5779.69%. This contributed to the annual value of 0.54 for FY2024, which is N/A changed from last year.
  • Per Kura Oncology's latest filing, its Equity Ratio stood at 0.37 for Q3 2025, which was down 5779.69% from 0.45 recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Equity Ratio registered a high of 0.91 during Q1 2024, and its lowest value of 0.37 during Q3 2025.